Flora Growth (FLGC) Competitors $18.56 +0.56 (+3.11%) Closing price 04:00 PM EasternExtended Trading$18.53 -0.03 (-0.16%) As of 04:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FLGC vs. VNRX, ESLA, KPTI, LTRN, MRSN, TPST, NBRV, RVPH, PDSB, and CALCShould you be buying Flora Growth stock or one of its competitors? The main competitors of Flora Growth include VolitionRx (VNRX), Estrella Immunopharma (ESLA), Karyopharm Therapeutics (KPTI), Lantern Pharma (LTRN), Mersana Therapeutics (MRSN), Tempest Therapeutics (TPST), Nabriva Therapeutics (NBRV), Reviva Pharmaceuticals (RVPH), PDS Biotechnology (PDSB), and CalciMedica (CALC). These companies are all part of the "pharmaceutical products" industry. Flora Growth vs. Its Competitors VolitionRx Estrella Immunopharma Karyopharm Therapeutics Lantern Pharma Mersana Therapeutics Tempest Therapeutics Nabriva Therapeutics Reviva Pharmaceuticals PDS Biotechnology CalciMedica VolitionRx (NYSE:VNRX) and Flora Growth (NASDAQ:FLGC) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, analyst recommendations, risk, media sentiment, earnings and dividends. Do insiders & institutionals hold more shares of VNRX or FLGC? 8.1% of VolitionRx shares are held by institutional investors. Comparatively, 36.0% of Flora Growth shares are held by institutional investors. 10.4% of VolitionRx shares are held by company insiders. Comparatively, 12.6% of Flora Growth shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the media favor VNRX or FLGC? In the previous week, VolitionRx had 3 more articles in the media than Flora Growth. MarketBeat recorded 5 mentions for VolitionRx and 2 mentions for Flora Growth. VolitionRx's average media sentiment score of 1.18 beat Flora Growth's score of 0.26 indicating that VolitionRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment VolitionRx 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Flora Growth 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger earnings and valuation, VNRX or FLGC? Flora Growth has higher revenue and earnings than VolitionRx. VolitionRx is trading at a lower price-to-earnings ratio than Flora Growth, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVolitionRx$1.32M36.51-$35.32M-$0.25-1.79Flora Growth$52.37M0.25-$15.91M-$34.38-0.54 Do analysts prefer VNRX or FLGC? VolitionRx currently has a consensus price target of $3.50, suggesting a potential upside of 681.77%. Flora Growth has a consensus price target of $93.00, suggesting a potential upside of 401.08%. Given VolitionRx's stronger consensus rating and higher possible upside, equities research analysts clearly believe VolitionRx is more favorable than Flora Growth.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VolitionRx 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00Flora Growth 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Is VNRX or FLGC more profitable? Flora Growth has a net margin of -24.86% compared to VolitionRx's net margin of -2,321.14%. VolitionRx's return on equity of 0.00% beat Flora Growth's return on equity.Company Net Margins Return on Equity Return on Assets VolitionRx-2,321.14% N/A -163.39% Flora Growth -24.86%-261.57%-48.06% Which has more volatility & risk, VNRX or FLGC? VolitionRx has a beta of 1.27, suggesting that its stock price is 27% more volatile than the S&P 500. Comparatively, Flora Growth has a beta of 1.93, suggesting that its stock price is 93% more volatile than the S&P 500. SummaryVolitionRx and Flora Growth tied by winning 8 of the 16 factors compared between the two stocks. Get Flora Growth News Delivered to You Automatically Sign up to receive the latest news and ratings for FLGC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FLGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FLGC vs. The Competition Export to ExcelMetricFlora GrowthMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$13.22M$10.84B$6.17B$10.68BDividend YieldN/A1.88%5.70%4.84%P/E Ratio-0.5420.9229.4727.36Price / Sales0.2528.14589.24132.03Price / CashN/A25.1225.8230.35Price / Book1.523.4912.526.69Net Income-$15.91M$208.83M$3.32B$276.59M7 Day Performance2.48%0.78%2.43%0.97%1 Month Performance-31.76%1.19%8.78%3.95%1 Year Performance-70.44%-8.19%62.11%36.40% Flora Growth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FLGCFlora Growth2.2259 of 5 stars$18.56+3.1%$93.00+401.1%-71.3%$13.22M$52.37M-0.54280Short Interest ↑Gap UpVNRXVolitionRx2.9106 of 5 stars$0.45-2.5%$3.50+673.1%-39.4%$48.71M$1.32M-1.2680Positive NewsGap UpHigh Trading VolumeESLAEstrella Immunopharma2.9029 of 5 stars$1.50+16.3%$16.00+966.7%+101.1%$47.81MN/A-5.77N/APositive NewsShort Interest ↓High Trading VolumeKPTIKaryopharm Therapeutics4.2811 of 5 stars$5.62+2.2%$18.20+223.8%-54.6%$47.69M$145.24M-0.39380LTRNLantern Pharma1.6322 of 5 stars$4.41+1.6%$25.00+466.9%+15.4%$46.87MN/A-2.4820Gap UpMRSNMersana Therapeutics4.1561 of 5 stars$9.91+7.3%$56.60+471.1%-81.2%$46.11M$40.50M-0.68150High Trading VolumeTPSTTempest Therapeutics1.471 of 5 stars$11.53+12.3%$30.00+160.2%-29.1%$45.60MN/A-0.7920Gap UpNBRVNabriva TherapeuticsN/AN/AN/AN/A$45.46M$35.59M0.0070RVPHReviva Pharmaceuticals2.9282 of 5 stars$0.63-3.8%$4.86+676.5%-59.5%$45.06MN/A-0.965Gap UpPDSBPDS Biotechnology1.2505 of 5 stars$0.96+0.9%$10.00+946.2%-71.5%$44.55MN/A-1.0420CALCCalciMedica3.2341 of 5 stars$3.26+3.2%$16.00+390.8%-21.3%$44.22MN/A-2.0430 Related Companies and Tools Related Companies VNRX Competitors ESLA Competitors KPTI Competitors LTRN Competitors MRSN Competitors TPST Competitors NBRV Competitors RVPH Competitors PDSB Competitors CALC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FLGC) was last updated on 10/20/2025 by MarketBeat.com Staff From Our PartnersThe End of Elon Musk…?While headlines point to collapsing sales and fading tax credits, tech analyst Jeff Brown says Tesla is on the...Brownstone Research | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredTrump’s “Smart Dollar” just went mainstream"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredWhat the hell is going on, America?America’s $37.5 trillion debt spiral, soaring deficits, and repeated credit downgrades are exactly what Porter...Porter & Company | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredGold surges past $4,200 … but this has beat gold by 1,000xGold has surged past $4,200 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Flora Growth Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Flora Growth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
